The Subcutaneous Immunoglobulin (SCIg) Home Infusion Program supports patients with at-home immunoglobulin therapy by teaching patients how to perform subcutaneous infusion (independently or with the assistance of a support person) and by providing on-going support / case-management.
Immunoglobulin (Ig) replacement therapy is primarily indicated for patients with Primary Immune Disorders in which the immune system cannot produce enough of its own infection-fighting proteins. Ig therapy can also be used to manage Secondary Immune Disorders (e.g. caused by treatments for cancer, auto-immune disease) and for other indicated conditions related to Hematology, Neuromuscular, Dermatology, Transplant Medicine, Infectious Disease, Rheumatology, and others.
Ig is typically a lifelong treatment that is required to provide either immune support or to manage symptoms of certain disorders. Traditionally, Ig is administered to patients monthly (or more often) through intravenous infusion, given by nurses in out-patient infusion clinics (e.g.: Day Medicine).
For patients who qualify, Ig therapy can also be provided by subcutaneous immunoglobulin (or SCIg) infusion, which can be performed by the patient independently, at home, at weekly (or other) intervals.
The SCIg Home Infusion Program works to support patients receiving SCIg therapy by providing in-person training (for patients, training partners, and/or caregivers), coordination of product ordering, and on-going case-management.